Many of the largest publicly traded US health insurers had a difficult second quarter as rising costs associated with ...

Humana lowered its full-year 2025 GAAP EPS guidance to approximately $13.77, down from $14.68. At the same time, it raised its adjusted EPS outlook to about $17.00, up from $16.25, citing ongoing ...

Simon Property Group (SPG) recently announced a partnership with Humana to launch the Humana Walking Club at 21 of its centers. This initiative aims to foster community engagement and promote health ...

Humana beat Q2 EPS and revenue estimates and raised its 2025 outlook, driven by strong PDP growth and higher CenterWell patient volumes.

In conclusion, Humana’s earnings call conveyed a positive outlook, driven by strong performances in key areas like CenterWell Pharmacy and improved membership retention. While challenges such as Stars ...

Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Humana raised its outlook for the year to be at least $128 billion, following better-than-expected revenue growth in its latest quarter.

U.S. equities were mixed at midday with the market reacting to a strong report on the U.S. economy while awaiting the Federal ...

Humana raised its full-year outlook as it anticipates a smaller decline in Medicare Advantage membership than originally expected.

Humana (HUM) stock jumps as the company with its Q2 results lifts its 2025 outlook, citing strength in its Medicare Advantage and Center Well businesses. Read more here.

Humana’s stock surges, after the health insurer raises its full-year profit outlook and sees improvement in its Medicare Advantage business.